Stage IIB Prostate Cancer Terminated Phase 2 Trials for Perifosine (DB06641)

IndicationStatusPhase
DBCOND0028879 (Stage IIB Prostate Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00058214Perifosine in Treating Patients With Recurrent Prostate CancerTreatment